CN101016283A - 喷雾干燥法制备炎琥宁 - Google Patents
喷雾干燥法制备炎琥宁 Download PDFInfo
- Publication number
- CN101016283A CN101016283A CN 200710008665 CN200710008665A CN101016283A CN 101016283 A CN101016283 A CN 101016283A CN 200710008665 CN200710008665 CN 200710008665 CN 200710008665 A CN200710008665 A CN 200710008665A CN 101016283 A CN101016283 A CN 101016283A
- Authority
- CN
- China
- Prior art keywords
- potassium sodium
- dehydroandroan drographolide
- sodium dehydroandroan
- reaction soln
- drographolide succinate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007100086657A CN101016283B (zh) | 2007-03-07 | 2007-03-07 | 喷雾干燥法制备炎琥宁 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007100086657A CN101016283B (zh) | 2007-03-07 | 2007-03-07 | 喷雾干燥法制备炎琥宁 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101016283A true CN101016283A (zh) | 2007-08-15 |
CN101016283B CN101016283B (zh) | 2010-07-28 |
Family
ID=38725524
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007100086657A Active CN101016283B (zh) | 2007-03-07 | 2007-03-07 | 喷雾干燥法制备炎琥宁 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101016283B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008098329A2 (en) * | 2007-02-13 | 2008-08-21 | Aché Laboratórios Farmacêuticos S/A | Pharmaceutical composition, pharmaceutical product, obtaining processes of pharmaceutical compounds and use of such compounds for treating erectile dysfunction |
CN104570813A (zh) * | 2013-10-25 | 2015-04-29 | 仲兆准 | 喷雾干燥仪集成控制器 |
CN104744412A (zh) * | 2015-04-07 | 2015-07-01 | 重庆药友制药有限责任公司 | 一种炎琥宁化合物 |
-
2007
- 2007-03-07 CN CN2007100086657A patent/CN101016283B/zh active Active
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008098329A2 (en) * | 2007-02-13 | 2008-08-21 | Aché Laboratórios Farmacêuticos S/A | Pharmaceutical composition, pharmaceutical product, obtaining processes of pharmaceutical compounds and use of such compounds for treating erectile dysfunction |
WO2008098329A3 (en) * | 2007-02-13 | 2009-02-05 | Ache Lab Farmaceuticos Sa | Pharmaceutical composition, pharmaceutical product, obtaining processes of pharmaceutical compounds and use of such compounds for treating erectile dysfunction |
CN104570813A (zh) * | 2013-10-25 | 2015-04-29 | 仲兆准 | 喷雾干燥仪集成控制器 |
CN104744412A (zh) * | 2015-04-07 | 2015-07-01 | 重庆药友制药有限责任公司 | 一种炎琥宁化合物 |
Also Published As
Publication number | Publication date |
---|---|
CN101016283B (zh) | 2010-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102584752B (zh) | 一种炎琥宁原料药制备方法 | |
CN110563600B (zh) | 一种磷酸奥司他韦的制备方法 | |
CN101016283B (zh) | 喷雾干燥法制备炎琥宁 | |
CN103420881B (zh) | 一种新的药用消旋羟蛋氨酸钙的制备方法 | |
CN108586360B (zh) | 一种6-氯-3-甲基尿嘧啶的制备方法 | |
CN107698578A (zh) | 一种噻虫嗪的制备方法 | |
CN100497309C (zh) | 杂芳环缩氨基硫脲类抗肿瘤药物的合成方法 | |
WO2016127890A1 (zh) | 一种草甘膦农药活性组合物及其制备方法 | |
CN103087017A (zh) | 炎琥宁粗品精制方法 | |
CN104844593A (zh) | 一种阿哌沙班药物中间体的合成方法 | |
CN104744390A (zh) | 一种依折麦布中间体酮的制备方法 | |
CN103113330A (zh) | 炎琥宁成盐工艺 | |
CN111848535B (zh) | 一种合成1h-四氮唑乙酸的工艺 | |
CN107383062A (zh) | 头孢布烯母核7‑ance的制备方法 | |
CN107892676A (zh) | 头孢地尼活性硫酯的制备方法 | |
CN114702425A (zh) | (s)-2-氨基-(s)-3-[吡咯烷酮-2’]丙氨酸衍生物及中间体的制备方法 | |
CN103145639A (zh) | 2-甲基-4-(三氟甲基)噻唑-5-甲酸的制备方法 | |
CN106565621A (zh) | 一种异噁唑草酮的合成方法 | |
CN101824004B (zh) | 一种头孢布烯侧链的合成工艺 | |
CN110922345B (zh) | 一种福多司坦的合成方法 | |
CN104151275A (zh) | 炎琥宁化合物的制备方法 | |
CN110452165B (zh) | 一种2-甲基吡啶-4-甲酸的制备方法 | |
CN113788750B (zh) | 一种苯氧乙酸钠的制备方法 | |
CN103910695B (zh) | 一种非布索坦的合成方法 | |
CN112028838B (zh) | 一种2-乙氧基-5-氟尿嘧啶杂质的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Fujian Mindong Rejuvenation Pharmaceutical Co., Ltd. Assignor: Fuzhou Juying Pharmaceutical Co., Ltd. Contract record no.: 2010350000200 Denomination of invention: Preparation of tanhuning Granted publication date: 20100728 License type: Exclusive License Open date: 20070815 Record date: 20100825 |
|
DD01 | Delivery of document by public notice |
Addressee: Fuzhou Juying Pharmaceutical Co., Ltd. Document name: Notification that Application Deemed not to be Proposed |
|
ASS | Succession or assignment of patent right |
Owner name: MINDONG LIJIEXUN PHARMACEUTICAL CO., LTD., FUJIAN Free format text: FORMER OWNER: FUZHOU JUYING PHARMACEUTICAL CO., LTD. Effective date: 20130305 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 350007 FUZHOU, FUJIAN PROVINCE TO: 355300 NINGDE, FUJIAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130305 Address after: 355300 pharmaceutical industry zone (Lower Village), Zherong County, Fujian, Ningde Patentee after: Fujian Mindong Rejuvenation Pharmaceutical Co., Ltd. Address before: 350007 Fujian city in Fuzhou Province, Hongshan Road No. 68 building 6 Shida Technology City A Patentee before: Fuzhou Juying Pharmaceutical Co., Ltd. |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 355300 No.1 pharmaceutical industry road, Zherong County, Ningde City, Fujian Province Patentee after: Fujian Mindong lijiexin Pharmaceutical Co.,Ltd. Address before: 355300 Pharmaceutical Industrial Park (Xiacun), Zherong County, Ningde City, Fujian Province Patentee before: Fujian Mindong Rejuvenation Pharmaceutical Co.,Ltd. |